- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$182.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$59,500.00
7D
5.1%
1Y
53.0%
Bristol-Myers Squibb
Market Cap: US$137.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$22.97
7D
-0.1%
1Y
n/a
Bristol-Myers Squibb
Market Cap: AR$137.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$36,220.00
7D
4.3%
1Y
69.8%
Bayer
Market Cap: AR$48.4b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$31,300.00
7D
0.6%
1Y
n/a
Novo Nordisk
Market Cap: US$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.20
7D
5.0%
1Y
n/a
GSK
Market Cap: US$76.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.48
7D
4.7%
1Y
35.9%
Novo Nordisk
Market Cap: AR$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$11,130.00
7D
8.1%
1Y
n/a
GSK
Market Cap: AR$76.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,830.00
7D
3.3%
1Y
54.9%
Gilead Sciences
Market Cap: US$182.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$38.60
7D
3.6%
1Y
33.1%
Biogen
Market Cap: AR$32.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$27,240.00
7D
5.2%
1Y
91.5%
Amgen
Market Cap: US$240.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$15.30
7D
4.2%
1Y
62.6%
AstraZeneca
Market Cap: AR$193.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$67,800.00
7D
7.2%
1Y
24.7%
Amgen
Market Cap: AR$240.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$23,570.00
7D
5.2%
1Y
79.9%
Vertex Pharmaceuticals
Market Cap: AR$138.8b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,755.00
7D
5.9%
1Y
67.7%
Biogen
Market Cap: US$32.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.65
7D
3.9%
1Y
68.1%
Novartis
Market Cap: US$240.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$41.01
7D
4.0%
1Y
28.6%
Vertex Pharmaceuticals
Market Cap: US$138.8b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.66
7D
4.8%
1Y
n/a
Novartis
Market Cap: AR$243.9b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$64,100.00
7D
5.0%
1Y
49.2%
AstraZeneca
Market Cap: US$193.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$44.24
7D
6.5%
1Y
10.7%